We use cookies on our site to track usage and preferences. Learn more

CN Bio appoints Dr. Samantha Macro as Chief Financial Officer

  • Date 6 Jun 2023

CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems (MPS), today announced that it has appointed Dr. Samantha Macro as Chief Financial Officer. Samantha joins CEO, Dr Paul Brooks, on the executive team to guide all key commercial and strategic initiatives, drive revenue and shape CN Bio’s ongoing growth trajectory.

Samantha’s appointment becomes CN Bio’s third leadership-level appointment in the past six months, as the Company continues to scale and strengthen its senior team during this next phase of commercial development. Bringing extensive financial industry experience, including over 15 years in life sciences, Samantha will play a pivotal role in guiding and executing the decisions which will grow the Company’s OOC offerings across key global markets.

Read more

Join an ambitious, supportive community of world-class scientists, engineers and entrepreneurs

Read more